News
VALO Health Raises $110M in Series B Funding

Boston-based Valo Health Raises $300m Series B To Identify Molecules And Predict Their Ability To Be Used In Drugs (Daniel Mccoy/Wichita Business Journal)- Koch Disruptive Technologies has invested $110 million in a Boston-based company improving drug delivery.
A Boston, MA-based technology company focused on improving drug discovery and development has received a $110 million investment from Koch Disruptive Technologies (KDT). Additionally, the company closed its Series B round at $300m, bringing its total funding to over $450m. Funds will be used for scaling the Opal Computational Platform, working capital, and other general purposes.
Founded and led by David Berry, VALO Health provides the Opal Computational PlatformTM, which combines machine learning capabilities with patient data to develop therapeutic programs.
Through Opal, VALO scientists have identified associations between genetic markers and disease. This has enabled them to identify specific genes involved in gene activity. This initial focus has been on oncology, neurodegenerative, and cardiovascular diseases.
Founded by Flagship Pioneering, the company also has offices in Lexington, MA, San Francisco, CA, Princeton, NJ, and Branford, CT.
Read more latest News – In The Uk, A 5g Spectrum Auction Raises 1.23 Billion Euros

-
Business2 years ago
How to Do Long-Distance Moves with Children
-
Travel8 months ago
Quick Guide: Moving To Santa Rosa?
-
Real Estate2 years ago
Your Guide To Home Buying: Maximizing Your Investment
-
Real Estate2 years ago
Why Dubai Festival City is a Great Neighbourhood for Young Learners
-
Lifestyle2 years ago
How Do You Shade A Sunny Patio?
-
Biography3 years ago
Sydney Brooke Simpson Bio, Weight, Height, Net Worth, Business
-
Tech2 years ago
Basic Detail About The Servers Of Minecraft Game
-
Biography3 years ago
Dorýs Madden (Julius Erving Wife) Age, Bio, Children, Wiki, & Net Worth
Recent Comments